PROPHYLACTIC TREATMENT OF PATIENTS WITH CALCIUM STONE DISEASE

被引：0
|
作者：
DANIELSON, BG [1 ]
机构：
[1] UNIV HOSP UPPSALA,DEPT INTERNAL MED,UPPSALA,SWEDEN
来源：
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY | 1986年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：27 / 27
页数：1
相关论文
共 50 条
  • [41] Prophylactic effects of quercetin and hyperoside in a calcium oxalate stone forming rat model
    Wei Zhu
    Yun-fei Xu
    Yuan Feng
    Bo Peng
    Jian-ping Che
    Min Liu
    Jun-hua Zheng
    Urolithiasis, 2014, 42 : 519 - 526
  • [42] Prophylactic effects of quercetin and hyperoside in a calcium oxalate stone forming rat model
    Zhu, Wei
    Xu, Yun-fei
    Feng, Yuan
    Peng, Bo
    Che, Jian-ping
    Liu, Min
    Zheng, Jun-hua
    UROLITHIASIS, 2014, 42 (06) : 519 - 526
  • [43] URINARY-EXCRETION OF URATE IN PATIENTS WITH CALCIUM-OXALATE STONE DISEASE
    TISELIUS, HG
    LARSSON, L
    UROLOGICAL RESEARCH, 1983, 11 (06): : 279 - 283
  • [44] Bone mineral density measurement in patients with recurrent normocalciuric calcium stone disease
    Volkan Tugcu
    Emin Ozbek
    Bekir Aras
    Bedi Ozbay
    Filiz Islim
    Ali Ihsan Tasci
    Urological Research, 2007, 35 : 29 - 34
  • [45] Renal pelvic pressure in patients with stone disease in the course of treatment
    Mudraya, I.
    Khodyreva, L.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 40 - 40
  • [46] A PROGRAM FOR EVALUATION, CLASSIFICATION AND TREATMENT OF PATIENTS WITH RENAL STONE DISEASE
    TISELIUS, HG
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1986, : 26 - 26
  • [47] URINE COMPOSITION IN PATIENTS WITH CALCIUM STONE DISEASE BEFORE AND DURING FOLLOW-UP IN AN OUTPATIENT STONE CLINIC
    TISELIUS, HG
    SANDVALL, K
    UROLOGICAL RESEARCH, 1988, 16 (03): : 200 - 200
  • [48] EXPERIENCE WITH LONG-TERM THIAZIDE TREATMENT IN CALCIUM-OXALATE STONE DISEASE
    AHLSTRAND, C
    TISELIUS, HG
    LARSSON, L
    UROLOGICAL RESEARCH, 1984, 12 (01): : 45 - 45
  • [49] Course of calcium stone disease without treatment. What can we expect?
    Strohmaier, WL
    EUROPEAN UROLOGY, 2000, 37 (03) : 339 - 344
  • [50] Should we modify the principles of risk evaluation and recurrence preventive treatment of patients with calcium oxalate stone disease in view of the etiologic importance of calcium phosphate?
    Tiselius, Hans-Goran
    UROLITHIASIS, 2015, 43 (01) : S47 - S57
12345